DIN3356 Swing Check Valve

Model NO.: DIN3356
Flow Direction: Unidirection
Standard: DIN
Application: Industrial Usage, Water Industrial Usage, Household Usage, Pipeline
Body: Ci Di Ss
Seat: EPDM;NBR
Actuator: Hand Level
Disc: Ci/Di+Nickle Plated;CF8;CF8m
Inspection: API598
Face to Face: En558-1 20 Series
Trademark: Eathu
Transport Package: Check Valve Are Packed Into Plywood Case
Specification: DN 15- DN 1200
Origin: Qingdao, China
HS Code: 8481804090
Swing Check valve fields of application
Gate valves are widely used in water systems such as water treatment plants, distribution networks, potable water applications; Sewage systems such as sewage treatment plants, raw water, digested sewage,air applications ; Industrial systems such as chemical contaminated waste water, gases, industrial media, sea water applications and Food & Beverage systems such as washing and rinsing applications, conveying systems, potable water processing. 
Item Swing check valve
 
Standard 		Design and manufacture standard DIN3356
Face to face dimension DIN3202 F1
Flange drilling EN1092-2
 
 
 
Specification 		Norminal Pressure 1.6Mpa
Suitable Medium Water
Test Pressure Shell 2.4Mpa
Seat 1.76Mpa
Test Time DN50-DN150 60S
DN150 and up 120S
Temperature <100ºC
 
Product Features 		1 Full port
2 Solid and resilient disc
3 Bolted cover
5 Low torque operation
 
 
Material list 		Body CI/DI GGG40/GGG50
Wedge CI/DI GGG40/GGG50+EPDM
Stem 2cr13/SS304/SSS316
Seat Metal seat / EPDM seat
Bolts and Nuts Zinc plated carbon steel
Coating A Fusion Bonded Epoxy powder coated
B Spray Painting
 
 
 
 
Face to face dimension 		Size Length
DN40 200MM
DN50 230MM
DN65 290MM
DN80 310MM
DN100 350MM
DN125 400MM
DN150 480MM
DN200 600MM
DN250 730MM
DN300 850MM

DIN3356 Swing Check Valve

Inspection:
DIN3356 Swing Check Valve
Package: All check valves packed into plywood cases
DIN3356 Swing Check Valve

Company profile:
DIN3356 Swing Check Valve

Certificate:
DIN3356 Swing Check Valve
 

Ruxolitinib API And Intermediates

Ruxolitinib is an orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies.

Ruxolitinib is a Janus kinase inhibitor that is used in the treatment of intermediate or high risk myelofibrosis and resistant forms of polycythemia vera and graft-vs-host disease. Ruxolitinib is associated with transient and usually mild elevations in serum aminotransferase during therapy and to rare instances of self-limited, clinically apparent idiosyncratic acute liver injury and to cases of reactivation of hepatitis B in susceptible individuals.

Ruxolitinib cas 941678-49-5; INCB018424; Ruxolitinib (INCB018424); (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H-Pyrazol-1-Yl)-3-Cyclopentylpropanenitrile; INCB-018424; INCB 018424; UNII-82S8X8XX8H;

Ruxolitinib cas 941678-49-5,Ruxolitinib cas 2075-45-8,Ruxolitinib cas 269410-08-4,Ruxolitinib cas 941685-26-3,Ruxolitinib cas 941685-27-4 Offering.

Ruxolitinib cas 941678-49-5,Ruxolitinib cas 2075-45-8,Ruxolitinib cas 269410-08-4,Ruxolitinib cas 941685-26-3,Ruxolitinib cas 941685-27-4

 Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com